Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 18.830 | 18.830 | 0.000 |
Shares | 84.100 | 84.100 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.698 | 12.218 |
Price to Book | 2.511 | 1.976 |
Price to Sales | 3.458 | 1.552 |
Price to Cash Flow | 17.753 | 8.287 |
Dividend Yield | 0.396 | 2.655 |
5 Years Earnings Growth | 13.659 | 14.422 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.870 | 22.140 |
Communication Services | 0.060 | 11.388 |
Financial Services | 0.050 | 11.538 |
Consumer Cyclical | 0.020 | 20.361 |
Number of long holdings: 54
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sichuan Kelun Biotech | CNE1000062J1 | 11.96 | 170.70 | -1.22% | |
Hansoh Pharmaceutical Group | KYG549581067 | 10.15 | 18.24 | +1.33% | |
Keymed Biosciences Inc | - | 8.51 | - | - | |
Genscript Biotech Corp | KYG3825B1059 | 7.38 | 12.38 | -0.64% | |
Remegen | CNE1000048G6 | 6.07 | 31.00 | -5.05% | |
Innovent Biologics | KYG4818G1010 | 3.92 | 40.05 | +0.63% | |
Akeso | KYG0146B1032 | 3.48 | 48.70 | -2.01% | |
Beigene | KYG1146Y1017 | 3.23 | 103.60 | +1.67% | |
Hutchison China | KYG4672N1198 | 2.92 | 324.00 | -3.86% | |
Ascentage Pharma | KYG0519B1023 | 2.32 | 20.55 | -1.20% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
001668 | 20.35B | 6.43 | 2.27 | - | ||
China Universal Consumer Industries | 13.91B | 6.83 | -14.16 | 17.24 | ||
China Universal Selective Mixed Sec | 9.46B | 9.73 | -14.13 | 12.29 | ||
China Universal Blue Chip Equity Fu | 4.62B | 1.80 | -15.39 | 12.79 | ||
China Universal CSI 300 Dynamic Str | 4.21B | 7.52 | -1.09 | 10.07 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review